How GLP-1 Medicines Work Inside the Body?
The friendly science: three gentle effects, why dual-action exists, and a look at the family side by side.
Key takeaways
- They copy a gut hormone, so they work with your body.
- Three effects: steadier blood sugar, less hunger, feeling full longer.
- Dual-action medicines add a second hormone, GIP.
- Which one suits a person is a clinical decision.
The mechanism sounds technical, but the idea is simple: top up a signal your gut already sends, and let your body do the rest.
It helps to start with the hormone itself. GLP-1 stands for glucagon-like peptide-1, and your gut releases it naturally after you eat. Think of it as a quiet message that travels round the body saying, in effect, 'food has arrived — let's handle it sensibly'. The catch is that your own GLP-1 fades within minutes. The medicines are lab-made versions designed to last far longer, so that helpful message stays switched on instead of flickering off almost as soon as it appears.
Three gentle effects
By mimicking GLP-1 in a steadier, longer-lasting way, these medicines produce three effects that work together:
- Steadier blood sugar — prompting your body to release its own insulin when blood sugar rises after a meal, and mainly when it's needed.
- Less hunger — acting on appetite areas in the brain, so smaller amounts feel satisfying.
- Fuller for longer — slowing how quickly the stomach empties, so a meal lingers and stretches the feeling of fullness.
There's a nice logic to how these fit together. The medicine encourages insulin chiefly in response to a meal rather than around the clock, which is one reason it's less likely on its own to push blood sugar too low than some older treatments can.
Why it feels different from willpower
Because these medicines lean on a signal your body already uses, many people describe the experience as feeling more in control rather than restrained. Hunger eases on its own, so eating a little less stops feeling like a fight you have to win at every meal. That's the same idea explored in our piece on food noise — the constant mental chatter about food often quietens, which is the change people tend to notice most.
One hormone, or two?
Most GLP-1 medicines copy just the one hormone, GLP-1. A newer, dual-action type also copies a second gut hormone called GIP — turning two dials at once instead of one. Working on two pathways together can make this approach especially effective for some people, for both blood sugar and weight.
Neither approach is simply 'better' across the board. A dual-action medicine isn't automatically the right choice — what suits one person may not suit another, which is exactly why this is a decision to make with a clinician rather than from a headline.
Meet the family
There are several medicines in this family, and the names can blur together. Tap a name below to see what each one is, how it's taken, and what it's mainly used for.
Ozempic (semaglutide)
Ozempic is a once-weekly semaglutide injection, licensed in the UK for type 2 diabetes. As one of the first GLP-1 medicines to become widely known, it now has a substantial body of real-world use behind it.
You give it to yourself with a pre-filled pen, into the fatty layer just beneath the skin of the tummy, thigh or upper arm. The dose begins low and steps up over several weeks — an unhurried climb that lets the body settle and keeps early effects mild.
For many people it settles blood sugar into a steadier range, and appetite tends to ease as the dose builds — which is why some also lose a little weight while on it. Like the rest of the family, it does its best work alongside everyday eating and activity.
A common mix-up: Ozempic's licence is for diabetes. The very same drug, semaglutide, is sold as Wegovy when it is prescribed for weight management.
Wegovy (semaglutide)
Wegovy is a once-weekly semaglutide injection licensed in the UK specifically for weight management — the same active drug as Ozempic, under a different licence. It is the clearest example of one molecule approved under two names for two jobs.
As with the other pens, it goes just under the skin, and the dose is built up in steps over a couple of months. That gradual approach is deliberate: it gives the body time to adjust and keeps the settling-in effects as gentle as possible.
It works by easing appetite and helping fullness arrive sooner, so eating less stops feeling like a test of willpower. The effect is strongest, and longest-lasting, when paired with healthier eating and more movement — exactly how it is meant to be used.
Because it nudges a natural appetite signal rather than forcing anything, people often describe feeling more in control around food rather than deprived.
Rybelsus (semaglutide)
Rybelsus is semaglutide in tablet form — the same family as Ozempic and Wegovy, but swallowed once a day rather than injected. For anyone wary of needles, that makes it a genuinely welcome option.
Timing matters more with the tablet: it is taken first thing on an empty stomach with a small sip of plain water, after which you wait a while before eating, drinking or taking other medicines so it can absorb. Tying it to a fixed morning moment makes this effortless.
It is currently used for type 2 diabetes. Studies have generally found the weekly injection a little stronger than today's tablet, but for many the simplicity of a daily pill more than makes up for that — and the appetite-steadying effect is the same reassuring one.
Needle-free GLP-1 options are an active area of research, so the choice of tablets is likely to keep growing.
Mounjaro (tirzepatide)
Mounjaro is a once-weekly tirzepatide injection from Eli Lilly, and it is the newest turn in this story: a dual-action treatment used for both type 2 diabetes and weight management.
What sets it apart is that it copies two gut hormones rather than one — GLP-1 plus a second called GIP. Working on two pathways at once is like turning two dials together, which can make it especially effective for some people, for both blood sugar and weight.
Day to day it feels much like the other weekly pens: a small injection just under the skin, with the dose eased upward gradually so the body adjusts and side effects stay gentle.
Whether a dual-action medicine suits someone better than a single-action one depends entirely on the person — a decision to weigh up with a clinician.
Saxenda / Victoza (liraglutide)
Saxenda and Victoza are two names for the same drug, liraglutide: Saxenda for weight management and Victoza for type 2 diabetes. Unlike the weekly options, liraglutide is a once-daily injection.
Because it is taken every day, it suits people who like a steady, predictable rhythm — and a daily habit can be easier to keep, much like any other once-a-day routine. It is given by pre-filled pen into the fat just under the skin.
As one of the earlier GLP-1 medicines, liraglutide carries a long, reassuring track record. For anyone cautious about trying something newer, that depth of experience can be comforting.
It does the same gentle work as its relatives — steadying blood sugar and softening appetite — only delivered as a daily dose rather than a weekly one.
Trulicity (dulaglutide)
Trulicity is a once-weekly dulaglutide injection from Eli Lilly, used for type 2 diabetes. It is single-action, copying the one gut hormone, GLP-1.
It is especially well known for an easy, no-fuss pen — nothing to dial or mix — and it can be taken on the same day each week, with or without food. Many people find the device reassuring and straightforward.
Like the rest of the family it steadies blood sugar by prompting the body to release its own insulin at the right time, and gently eases appetite as a bonus. The dose steps up slowly so side effects stay mild while you settle in.
A once-a-week schedule plus a fuss-free pen makes it a popular, low-effort choice for managing type 2 diabetes.
Side by side
Sometimes it's clearest to see them lined up together. This compares form, frequency and licensed use at a glance. (No prices — and remember that which one suits a person is always a clinical decision, not something to choose from a table.)
| Brand | Active drug | Form | How often | Mainly for |
|---|---|---|---|---|
| Ozempic | semaglutide | Injection | Weekly | Type 2 diabetes |
| Wegovy | semaglutide | Injection | Weekly | Weight management |
| Rybelsus | semaglutide | Tablet | Daily | Type 2 diabetes |
| Mounjaro | tirzepatide | Injection | Weekly | Diabetes & weight |
| Saxenda / Victoza | liraglutide | Injection | Daily | Weight loss / diabetes |
| Trulicity | dulaglutide | Injection | Weekly | Type 2 diabetes |
What this means for you
The takeaway is gentler than the science sounds. These medicines don't override your body or force anything to happen. They extend a natural signal, and the rest follows. That's also why they're not a standalone fix: they work best with the everyday habits your appetite system already responds to.
Not a stimulant These don't force your body to burn anything, and they aren't related to old-style 'fat burners'. They work best with the everyday habits the same system already responds to: regular meals, movement and rest.
Sources
- manufacturer prescribing information
- peer-reviewed clinical pharmacology references
- NHS